Moreover, a 25–50% reduction in the Scn8a transcript can delay seizure onset and lethality not only in mouse models of Scn8a encephalopathy but also in the mouse model of Dravet syndrome [77]. This evidence concerns the gene SCN8A and Dravet syndrome.